Your browser doesn't support javascript.
loading
Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.
Liao, Yuwei; Ma, Zhaokui; Zhang, Yu; Li, Dan; Lv, Dekang; Chen, Zhisheng; Li, Peiying; Ai-Dherasi, Aisha; Zheng, Feng; Tian, Jichao; Zou, Kun; Wang, Yue; Wang, Dongxia; Cordova, Miguel; Zhou, Huan; Li, Xiuhua; Liu, Dan; Yu, Ruofei; Zhang, Qingzheng; Zhang, Xiaolong; Zhang, Jian; Zhang, Xuehong; Zhang, Xia; Li, Yulong; Shao, Yanyan; Song, Luyao; Liu, Ruimei; Wang, Yichen; Sufiyan, Sufiyan; Liu, Quentin; Owen, Gareth I; Li, Zhiguang; Chen, Jun.
Affiliation
  • Liao Y; The Second Hospital of Dalian Medical University, Dalian, China.
  • Ma Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li D; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Lv D; The Second Hospital of Dalian Medical University, Dalian, China.
  • Chen Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li P; The Second Hospital of Dalian Medical University, Dalian, China.
  • Ai-Dherasi A; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zheng F; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Tian J; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
  • Zou K; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang Y; The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Wang D; The Second Hospital of Dalian Medical University, Dalian, China.
  • Cordova M; The Second Hospital of Dalian Medical University, Dalian, China.
  • Zhou H; Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Li X; The Second Hospital of Dalian Medical University, Dalian, China.
  • Liu D; The Second Hospital of Dalian Medical University, Dalian, China.
  • Yu R; The Second Hospital of Dalian Medical University, Dalian, China.
  • Zhang Q; The Second Hospital of Dalian Medical University, Dalian, China.
  • Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Shao Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Song L; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu R; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Sufiyan S; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu Q; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Owen GI; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li Z; Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Chen J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Cancer Med ; 8(12): 5673-5686, 2019 09.
Article in En | MEDLINE | ID: mdl-31369215
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Receptor, Notch1 / High-Throughput Nucleotide Sequencing / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Receptor, Notch1 / High-Throughput Nucleotide Sequencing / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: China Country of publication: Estados Unidos